Interleukin 12, interleukin 18, and tumor necrosis factor α release by alveolar macrophages: Acute and chronic hypersensitivity pneumonitis

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 2, 2009, Pages 149-154

  Ye, Qiao ^a,b   Nakamura, Shinobu ^c   Sarria, Rafael ^d   Costabel, Ulrich ^a   Guzman, Josune ^e  

^a RUHRLANDKLINIK   (Germany)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; ALLERGIC PNEUMONITIS; ARTICLE; CD4 CD8 RATIO; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SUPERNATANT;

EID: 60849110583     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60246-3     Document Type: Article

References (26)

1. Costabel U. The alveolitis of hypersensitivity pneumonitis. Eur Respir J. 1988;1:5-9.
2. Costabel U, Guzman J. Hypersensitivity pneumonitis. In: Baughman RP, du Bois RM, eds. Diffuse Lung Disease: A Practical Approach. London, England: Arnold; 2004:203-212.
3. Selman M. Hypersensitivity pneumonitis. In: Schwarz MI, King TE, eds. Interstitial Lung Disease. 4th ed. London, England: BC Decker, Hamilton; 2003:452-484.
4. Mohr LC. Hypersensitivity pneumonitis. Curr Opin Pulm Med. 2004; 10:401-411.
5. + cells adoptively transfer experimental hypersensitivity pneumonitis. Cell Immunol. 1997; 177:169.
6. Yamasaki H, Ando M, Brazer W, Center DM, Cruikshank WW. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol. 1999;163:3516-3523.
7. Gudmundsson G, Hunninghake GW. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest. 1997;99:2386-2390.
8. Nance S, Cross R, Yi AK, Fitzpatrick EA. IFN-γ production by innate immune cells is sufficient for development of hypersensitivity pneumonitis. Eur J Immunol. 2005;35:1928-1938.
9. Gudmundsson G, Monick M, Hunninghake GW. IL-12 modulates expression of hypersensitivity pneumonitis. J Immunol. 1998;161: 991-999.
10. Schuyler M, Gott K, Cherne A. Is IL12 necessary in experimental hypersensitivity pneumonitis? Int J Exp Path. 2002;83:87-98.
11. Chen B, Tong Z, Nakamura S, Costabel U, Guzman J. Production of IL-12, IL-18 and TNF-alpha by alveolar macrophages in hypersensitivity pneumonitis. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:199-203.
12. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M. Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol. 1991;5:477-483.
13. Denis M, Bedard M, Laviolette M, Cormier Y. A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. Am Rev Respir Dis. 1993;147:934-939.
14. Schaaf BM, Seitzer U, Pravica V, Aries SP, Zabel P. Tumor necrosis factor-α-308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am J Respir Crit Care Med. 2001;163:379-382.
15. Schuyler M, Gott K, Cherne A. Mediators in hypersensitivity pneumonitis. J Lab Clin Med. 2000;136:29-38.
16. Costabel U, Bross KJ, Matthys H. The immunoperoxidase slide assay: a new method for the demonstration of surface antigens on bronchoalveo-lar lavage cells. Bull Eur Physiopathol Respir. 1985;21:381-387.
17. Nakanisch K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423-474.
18. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol. 2000;12:59-63.
19. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol. 1998;161:3400-3407.
20. Okamoto I, Kohno K, Tanimoto T, Ikegami H, Kurimoto M. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J Immunol. 1999;162:3202-3211.
21. Costabel U. Bronchoalveolar lavage cell differentials and lymphocyte subsets in hypersensitivity pneumonitis. Rev Port Pneumol. 2000;4:187-193.
22. Ando M, Konishi K, Yoneda R, Tamura M. Difference in the pheno-types of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol. 1991;87:1002-1009.
23. Cormier Y, Belanger J, Laviolette M. Prognostic significance of bron-choalveolar lavage lymphocytosis in farmer's lung. Am Rev Respir Dis. 1987;135:692-695.
24. Wahlstrom J, Berlin M, Lundgren R, et al. Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J. 1997;10:772-779.
25. Drent M, van Velzen-Blad H, Diamant M, et al. Bronchoalveolar lavage in extrinsic allergic alveolitis: effect of time elapsed since antigen exposure. Eur Respir J. 1993;6:1276-1281.
26. Trentin L, Marcer G, Chilosi M, et al. Longitudinal study of alveolitis in hypersensitivity pneumonitis patients: an immunological evaluation. J Allergy Clin Immunol. 1988;82:577-585.